Legend Biotech (LEGN) Return on Sales (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales climbed to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q1 2024 and bottomed at 0.16% in Q2 2022.
• A 5-year average of 0.02% and a median of 0.01% in 2022 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales retreated 12 bps — and 2023, when it climbed 13 bps.
• Year by year, Return on Sales stood at 0.02% in 2021, then plunged by 126 bps to 0.05% in 2022, then jumped by 100 bps to 0.0% in 2023, then jumped by 16004 bps to 0.0% in 2024, then tumbled by 109 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison